IhabRKamelMD

Radiology • Aurora, CO

Professor of Radiology and Radiological Science, Professor of Oncology, Johns Hopkins University School of Medicine; Clinical Director, MRI

Join to view full profile

Are you Dr. Kamel?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 65 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
12605 E 16th Ave
Aurora, CO 80045
Phone+1 720-848-0000

Summary

Dr. Ihab Kamel, MD is a board certified radiologist in Aurora, Colorado. He is currently licensed to practice medicine in Colorado, District of Columbia, and Georgia. He is affiliated with Johns Hopkins Bayview Medical Center and is a Professor of Radiology and Radiological Science at Johns Hopkins University School of Medicine; Clinical Director.

Education & Training

Westchester Medical CenterResidency, Radiology-Diagnostic, 1994 - 1998
Cairo University School of MedicineClass of 1983

Certifications & Licensure

MD State Medical License 2000 - 2026
CO State Medical License 2023 - 2025
DE State Medical License 2008 - 2025
GA State Medical License 2014 - 2025
MA State Medical License 1998 - 2025
DC State Medical License 2017 - 2024
MI State Medical License 1993 - 1995
American Board of Radiology Diagnostic Radiology

Clinical Trials

Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI. Start of enrollment: 2007 Sep 01
Completed
Not Applicable
Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer Start of enrollment: 2013 Apr 01
Completed
Phase 2
Doxorubicin-eluting LC Bead M1 for Patients With Hepatocellular Carcinoma Start of enrollment: 2014 Feb 01
Completed
Phase 2
Irinotecan -Eluting LC Bead-M1 (DEBIRI-M1) for Patients With Liver Metastases From Colorectal Cancer Start of enrollment: 2014 Feb 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

50 citations
Intrahepatic Cholangiocarcinoma Treated with Local-Regional Therapy: Quantitative Volumetric Apparent Diffusion Coefficient Maps for Assessment of Tumor Response
Vivek Gowdra Halappa, Susanne Bonekamp, Celia P. Corona-Villalobos, Zhen Li, Margaret Mensa
Radiology. 2012-07-01
249 citations
Phase II Trial of Sorafenib Combined With Concurrent Transarterial Chemoembolization With Drug-Eluting Beads for Hepatocellular Carcinoma
Timothy M. Pawlik, Diane K. Reyes, David Cosgrove, Ihab R. Kamel, Nikhil Bhagat
Journal of Clinical Oncology. 2011-10-20
18 citations
Trends and patterns of utilization in post-treatment surveillance imaging among patients treated for hepatocellular carcinoma.
Omar Hyder, Rebecca M. Dodson, Matthew J. Weiss, David Cosgrove, Joseph M. Herman
Journal of Gastrointestinal Surgery. 2013-08-14

Authored Content

The MR Radiomic Signature Can Predict Preoperative Lymph Node Metastasis in Patients with Esophageal CancerJuly 2018
Author’s ReplyFebruary 2018
Safety of Magnetic Resonance Imaging in Patients with Cardiac DevicesDecember 2017
Safety of Magnetic Resonance Imaging in Patients with Cardiac DevicesDecember 2017
Safety of Magnetic Resonance Imaging in Patients with Cardiac DevicesDecember 2017
ACR Appropriateness Criteria® Chronic Liver DiseaseNovember 2017
ACR Appropriateness Criteria® Chronic Liver DiseaseMay 2017
Join now to see all

Press Mentions

American College of Radiology Updates Imaging Appropriateness Criteria with 8 New TopicsOctober 29th, 2024
Ihab Kamel, MD, PhD, Named Chair of Department of RadiologyAugust 6th, 2023

Other Languages

Arabic